Atossa Therapeutics Inc (NASDAQ:ATOS)

Delayed Data
As of Nov 30
 +0.013 / +1.78%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 4.75, with a high estimate of 5.50 and a low estimate of 4.00. The median estimate represents a +539.21% increase from the last price of 0.74.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Atossa Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -30.00%
Growthannually -14.29%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.